Product Information
LACOSAMIDE 150 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.2127 per EA under NDC 51991035006. Its NADAC has been published 218 times since Jun 22, 2022.
FDA first approved this application on Mar 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991035006
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204921FDA Approved
3/17/2022
TE Code
AB
On Market Since
3/18/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 150 MG TABLET has been published 218 times since Jun 22, 2022, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2127 per EA |
|---|---|
| All-time high | $0.4317 (Jul 13, 2022) |
| All-time low | $0.2033 (Jul 22, 2026) |
| 52-week high | $0.2502 |
| 52-week low | $0.2033 |
| Median price | $0.3037 |
| Average price | $0.3152 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 218 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LACOSAMIDE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 150 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.2127 per EA (NDC 51991035006), effective Aug 19, 2026.
How has the price of LACOSAMIDE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 150 MG TABLET has declined 50.7%. It has been tracked across 218 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 150 MG TABLET?
Since Jun 22, 2022, the NADAC for LACOSAMIDE 150 MG TABLET has ranged from a low of $0.2033 (Jul 22, 2026) to a high of $0.4317 (Jul 13, 2022), with a median of $0.3037 per EA.
Are there cheaper alternatives to LACOSAMIDE 150 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LACOSAMIDE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LACOSAMIDE 150 MG TABLET?
LACOSAMIDE 150 MG TABLET (NDC 51991035006) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.